A New Methodological Approach for Cost-Effectiveness Analysis in Genomic Medicine
作者： Vasilios Fragoulakis , Christina Mitropoulou , Marc S. Williams , George P. Patrinos
DOI: 10.1016/B978-0-12-801497-4.00008-4
关键词:
摘要: In this chapter, we introduce illustratively the decision-making process of classical theory with a new model and methodological concept cost-effectiveness analysis in genomic medicine. The proposed combines analysis, budget impact social preferences while relaxing assumption that willingness to pay (λ) is indifferent actual difference effectiveness between interventions. This rational provides practical guide by which policymakers could ensure sustainability funding given restriction budget.
elsevier.com
sci-hub.se 参考文章(30)
Steffen Flessa, Where efficiency saves lives: a linear programme for the optimal allocation of health care resources in developing countries. Health Care Management Science. ,vol. 3, pp. 249- 267 ,(2000) , 10.1023/A:1019053710258
Eva-Julia Weyler, Afschin Gandjour, Empirical Validation of Patient versus Population Preferences in Calculating QALYs Health Services Research. ,vol. 46, pp. 1562- 1574 ,(2011) , 10.1111/J.1475-6773.2011.01268.X
Maria Knoph Kvamme, Dorte Gyrd-Hansen, Jan Abel Olsen, Ivar Sønbø Kristiansen, Increasing marginal utility of small increases in life-expectancy?: Results from a population survey Journal of Health Economics. ,vol. 29, pp. 541- 548 ,(2010) , 10.1016/J.JHEALECO.2010.03.010
John F.P. Bridges, Eberechukwu Onukwugha, C. Daniel Mullins, Healthcare Rationing by Proxy PharmacoEconomics. ,vol. 28, pp. 175- 184 ,(2010) , 10.2165/11530650-000000000-00000
Marianthi Georgitsi, Emmanouil Viennas, Vassiliki Gkantouna, Elena Christodoulopoulou, Zoi Zagoriti, Christina Tafrali, Fotios Ntellos, Olga Giannakopoulou, Athanassia Boulakou, Panagiota Vlahopoulou, Eva Kyriacou, John Tsaknakis, Athanassios Tsakalidis, Konstantinos Poulas, Giannis Tzimas, George P Patrinos, Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbase. Pharmacogenomics. ,vol. 12, pp. 49- 58 ,(2011) , 10.2217/PGS.10.169
William S. Cartwright, Methods for the economic evaluation of health care programmes, second edition. By Michael F. Drummond, Bernie O'Brien, Greg L. Stoddart, George W. Torrance. Oxford: Oxford University Press, 1997. Journal of Mental Health Policy and Economics. ,vol. 2, pp. 43- 43 ,(1999) , 10.1002/(SICI)1099-176X(199903)2:1<43::AID-MHP36>3.0.CO;2-7
James Veney, Philip Williams, Theresa Hatzell, In search of failure: guidelines for ministries of health. World health and population. ,vol. 1, pp. 1- 15 ,(2013) , 10.12927/WHP..17483
Aaron L. Nelson, Joshua T. Cohen, Dan Greenberg, David M. Kent, Much Cheaper, Almost as Good: Decrementally Cost-Effective Medical Innovation Annals of Internal Medicine. ,vol. 151, pp. 662- 667 ,(2009) , 10.7326/0003-4819-151-9-200911030-00011
Christopher McCabe, Karl Claxton, Anthony J Culyer, The NICE cost-effectiveness threshold: what it is and what that means. PharmacoEconomics. ,vol. 26, pp. 733- 744 ,(2008) , 10.2165/00019053-200826090-00004
Amiram Gafni, Willingness to pay. What's in a name? PharmacoEconomics. ,vol. 14, pp. 465- 470 ,(1998) , 10.2165/00019053-199814050-00001